Unknown

Dataset Information

0

MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.


ABSTRACT: MicroRNA-130b (miR-130b) is involved in several biologic processes; its role in colorectal tumorigenesis has not been addressed so far. Herein, we demonstrate that miR-130b up-regulation exhibits clinical relevance as it is linked to advanced colorectal cancers (CRCs), poor patients' prognosis, and molecular features of enhanced epithelial-mesenchymal transition (EMT) and angiogenesis. miR-130b high-expressing cells develop large, dedifferentiated, and vascularized tumors in mouse xenografts, features that are reverted by intratumor injection of a specific antisense RNA. In contrast, injection of the corresponding mimic in mouse xenografts from miR-130b low-expressing cells increases tumor growth and angiogenic potential while reduces the epithelial hallmarks. These biologic effects are reproduced in human CRC cell lines. We identify peroxisome proliferator-activated receptor ? (PPAR?) as an miR-130b direct target in CRC in vitro and in vivo. Notably, the effects of PPAR? gain- and loss-of-function phenocopy those due to miR-130b down-regulation or up-regulation, respectively, underscoring their biologic relevance. Furthermore, we provide mechanistic evidences that most of the miR-130b-dependent effects are due to PPAR? suppression that in turn deregulates PTEN, E-cadherin, Snail, and vascular endothelial growth factor, key mediators of cell proliferation, EMT, and angiogenesis. Since higher levels of miR-130b are found in advanced tumor stages (III-IV), we propose a novel role of the miR-130b-PPAR? axis in fostering the progression toward more invasive CRCs. Detection of onco-miR-130b and its association with PPAR? may be useful as a prognostic biomarker. Its targeting in vivo should be evaluated as a novel effective therapeutic tool against CRC.

SUBMITTER: Colangelo T 

PROVIDER: S-EPMC3769887 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

Colangelo Tommaso T   Fucci Alessandra A   Votino Carolina C   Sabatino Lina L   Pancione Massimo M   Laudanna Carmelo C   Binaschi Monica M   Bigioni Mario M   Maggi Carlo Alberto CA   Parente Domenico D   Forte Nicola N   Colantuoni Vittorio V  

Neoplasia (New York, N.Y.) 20130901 9


MicroRNA-130b (miR-130b) is involved in several biologic processes; its role in colorectal tumorigenesis has not been addressed so far. Herein, we demonstrate that miR-130b up-regulation exhibits clinical relevance as it is linked to advanced colorectal cancers (CRCs), poor patients' prognosis, and molecular features of enhanced epithelial-mesenchymal transition (EMT) and angiogenesis. miR-130b high-expressing cells develop large, dedifferentiated, and vascularized tumors in mouse xenografts, fe  ...[more]

Similar Datasets

| S-EPMC4569941 | biostudies-literature
| S-EPMC5852242 | biostudies-literature
| S-EPMC4349874 | biostudies-literature
| S-EPMC5489885 | biostudies-literature
| S-EPMC5149564 | biostudies-literature
| S-EPMC7538709 | biostudies-literature
| S-EPMC7068240 | biostudies-literature
| S-EPMC7934273 | biostudies-literature
2011-08-31 | E-GEOD-16934 | biostudies-arrayexpress
| S-EPMC5173103 | biostudies-literature